文献速递类风湿关节炎

类风湿关节炎发展轨迹中自身免疫过程的时间顺序:我们已知什么?

Time sequence of autoimmune processes in the trajectory to rheumatoid arthritis development: what do we know?
PubMed 文献 · RMD Open · 2025-05-07

该综述按证据等级解读现有文献,探讨类风湿关节炎(RA)发展轨迹中无症状与有症状风险期的自身免疫过程时间顺序。抗环瓜氨酸肽抗体(ACPA)阳性RA的全身自身免疫反应成熟似乎发生在诊断前约5年,而有症状风险期及进展至RA期间自身免疫反应稳定。ACPA阴性RA的有症状风险期较ACPA阳性RA更长,但自身免疫成熟似乎也主要发生在无症状期。

要点

  • ACPA阳性RA的全身自身免疫反应成熟似乎发生在诊断前约5年。
  • ACPA阳性RA在有症状风险期及进展至RA期间自身免疫反应稳定。
  • 已知遗传和环境因素在两个风险期的作用不同。

核心结论

  • ACPA阳性疾病的全身自身免疫反应成熟似乎发生在诊断前约5年,但在有症状风险期和进展至RA期间自身免疫反应稳定。
  • ACPA阴性RA的有症状风险期较ACPA阳性RA更长,但其自身免疫成熟似乎也主要发生在无症状期。
  • 作者基于此提出了RA发展的新图像。

研究设计与样本

  • 综述:按证据等级解读当前可用文献,指出需在患者中重复测量的纵向研究才能对时间顺序得出稳健结论。

主要发现

  • ACPA阳性RA的全身自身免疫反应成熟似乎发生在诊断前约5年。
  • ACPA阳性RA在有症状风险期及进展至RA期间自身免疫反应稳定。
  • 已知遗传和环境因素在无症状风险期与有症状风险期的作用不同。
  • ACPA阴性RA的有症状风险期较ACPA阳性RA更长,但其自身免疫成熟似乎也主要发生在无症状期。

临床怎么用

  • 作者认为该知识可指导未来旨在预防RA的试验中治疗靶点的选择。

局限性

  • 已发表的RA发展视觉展示常将自身免疫反应成熟显示在有症状风险期或RA发展前相对较短时间,但支持该观点的证据有限。
  • 需在患者中重复测量的纵向研究才能对时间顺序得出稳健结论。
  • 关于ACPA阴性RA的发展所知较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The trajectory to RA development is a multi-step process that can take a decade. Understanding which processes occur at which moment during this trajectory is crucial when designing interventions to prevent disease development. Clinically, the period before RA onset can be divided into an asymptomatic and a symptomatic risk phase. Published visual representations of RA development often display the maturation of the autoimmune response occurring in the symptomatic risk phase or relatively short before RA development, but evidence underlying this notion is limited. To obtain more detailed insights into the time sequence of immune processes in the asymptomatic and symptomatic risk stages of RA development, we interpreted the current available literature against the level of evidence, as longitudinal studies with repeated measurements in patients are needed for a robust conclusion on temporal sequences. Regarding the development of ACPA-positive disease, maturation of the systemic autoimmune response seems to occur approximately 5-years before diagnosis, but the autoimmune response is stable during the symptomatic risk phase and progression to RA. Known genetic and environmental factors have a different effect in both risk phases. Less is known about the development of ACPA-negative RA, the symptomatic risk phase lasts longer than for ACPA-positive RA, but here too the maturation of the autoimmunity seems to take place mainly in the asymptomatic phase. Based on this, we have proposed a new picture of RA development. This knowledge can guide the choice of treatment targets in future trials aimed at preventing RA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Heutz JW, Toes REM, van der Helm-van Mil AHM, et al. Time sequence of autoimmune processes in the trajectory to rheumatoid arthritis development: what do we know? RMD Open. 2025. PMID: 40341182. doi:10.1136/rmdopen-2024-005377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。